EE200200576A - Oksasooli derivaadid ja nende kasutamine türosiini kinaasi inhibiitoritena - Google Patents
Oksasooli derivaadid ja nende kasutamine türosiini kinaasi inhibiitoritenaInfo
- Publication number
- EE200200576A EE200200576A EEP200200576A EEP200200576A EE200200576A EE 200200576 A EE200200576 A EE 200200576A EE P200200576 A EEP200200576 A EE P200200576A EE P200200576 A EEP200200576 A EE P200200576A EE 200200576 A EE200200576 A EE 200200576A
- Authority
- EE
- Estonia
- Prior art keywords
- tyrosine kinase
- kinase inhibitors
- oxazole derivatives
- oxazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000106836 | 2000-04-07 | ||
PCT/JP2001/002937 WO2001077107A1 (en) | 2000-04-07 | 2001-04-05 | Oxazole derivatives and their uses as tyrosine kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200200576A true EE200200576A (et) | 2004-06-15 |
Family
ID=18619943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200200576A EE200200576A (et) | 2000-04-07 | 2001-04-05 | Oksasooli derivaadid ja nende kasutamine türosiini kinaasi inhibiitoritena |
Country Status (19)
Country | Link |
---|---|
US (2) | US6716863B2 (et) |
EP (1) | EP1268473A1 (et) |
KR (1) | KR20020028865A (et) |
CN (1) | CN1444582A (et) |
AU (1) | AU2001244726A1 (et) |
BR (1) | BR0109851A (et) |
CA (1) | CA2404760A1 (et) |
CO (1) | CO5261589A1 (et) |
CZ (1) | CZ20023264A3 (et) |
EE (1) | EE200200576A (et) |
HU (1) | HUP0300434A3 (et) |
IL (1) | IL152115A0 (et) |
MX (1) | MXPA02009621A (et) |
NO (1) | NO20024742L (et) |
OA (1) | OA12244A (et) |
PE (1) | PE20011178A1 (et) |
PL (1) | PL365787A1 (et) |
SK (1) | SK14132002A3 (et) |
WO (1) | WO2001077107A1 (et) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000020034A1 (fr) * | 1998-10-08 | 2000-04-13 | Takeda Chemical Industries, Ltd. | Agents destines a retarder le passage d'un cancer hormono-dependant a un cancer hormono-independant |
EP1310491A1 (en) * | 2000-07-19 | 2003-05-14 | Takeda Chemical Industries, Ltd. | Method for producing 1-substituted-1,2,3-triazole derivative |
US20040235748A1 (en) * | 2001-04-25 | 2004-11-25 | Yasutaka Igari | Agents for preventing postoperative recurrence of premenopausal breast cancer |
WO2002087619A1 (fr) * | 2001-04-27 | 2002-11-07 | Takeda Chemical Industries, Ltd. | Methode de prevention et de traitement du cancer |
WO2002087618A1 (fr) * | 2001-04-27 | 2002-11-07 | Takeda Chemical Industries, Ltd. | Methode de prevention et de traitement du cancer |
US20050215528A1 (en) * | 2001-08-10 | 2005-09-29 | Shuichi Furuya | Gnrh agonist combination drugs |
US6984653B2 (en) * | 2001-10-05 | 2006-01-10 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof |
US7812044B2 (en) | 2001-11-13 | 2010-10-12 | Takeda Pharmaceutical Company Limited | Anticancer agents |
EP1460067A4 (en) * | 2001-11-26 | 2005-12-07 | Takeda Pharmaceutical | BICYCLIC DERIVATIVE, PROCESS FOR PRODUCTION OF THE DERIVATIVE, AND USE THEREOF |
WO2003059907A1 (fr) * | 2002-01-17 | 2003-07-24 | Takeda Chemical Industries, Ltd. | Composes heterocycliques azotes : procede de preparation et d'utilisation |
RU2376029C2 (ru) | 2002-04-25 | 2009-12-20 | Юниверсити Оф Коннектикут Хелт Сентер | Применение белков теплового шока для улучшения терапевтического эффекта невакцинного лечебного воздействия |
KR101072909B1 (ko) * | 2002-12-16 | 2011-10-17 | 깃세이 야쿠힌 고교 가부시키가이샤 | 경구고형의약 |
TW200505913A (en) * | 2003-03-28 | 2005-02-16 | Hoffmann La Roche | Novel oxazole derivatives, their manufacture and use as pharmaceutical agents |
TW200423931A (en) * | 2003-04-30 | 2004-11-16 | Hoffmann La Roche | Novel aniline derivatives, their manufacture and use as pharmaceutical agents |
US7247649B2 (en) | 2003-08-13 | 2007-07-24 | Hoffmann-La Roche Inc. | Oxazoles, their manufacture and use as pharmaceutical agents |
US7259262B2 (en) * | 2003-10-24 | 2007-08-21 | Hoffmann-La Roche Inc. | Arylazole derivatives, their manufacture and use as pharmaceutical agents |
US20050186275A1 (en) * | 2004-02-23 | 2005-08-25 | Standard Chem. & Pharm. Co. Ltd. | Sustained release tamsulosin formulations |
TW200612914A (en) * | 2004-03-05 | 2006-05-01 | Hoffmann La Roche | Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents |
TW200531688A (en) | 2004-03-05 | 2005-10-01 | Hoffmann La Roche | Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents |
TW200533346A (en) * | 2004-03-18 | 2005-10-16 | Hoffmann La Roche | Novel ether derivatives, their manufacture and use as pharmaceutical agents |
EP1758897A1 (en) | 2004-04-02 | 2007-03-07 | F.Hoffmann-La Roche Ag | Novel diazine derivatives, their manufacture and use as pharmaceutical agents |
US7005526B2 (en) * | 2004-05-25 | 2006-02-28 | Hoffmann-La Roche Inc. | Thioether derivatives |
US7163953B2 (en) * | 2004-05-25 | 2007-01-16 | Hoffmann-La Roche Inc. | Benzylether derivatives |
US7618769B2 (en) * | 2004-06-07 | 2009-11-17 | Applied Materials, Inc. | Textured chamber surface |
US7288557B2 (en) | 2004-09-21 | 2007-10-30 | Hoffmann-La Roche Inc. | Triazole derivatives |
US7342030B2 (en) * | 2004-09-22 | 2008-03-11 | Hoffmann-La Roche Inc. | Indole derivatives |
US20060069095A1 (en) * | 2004-09-24 | 2006-03-30 | Thomas Hofmeister | Azole derivatives |
US20060116407A1 (en) * | 2004-11-22 | 2006-06-01 | Birgit Bossenmaier | Amide derivatives |
TW200727900A (en) * | 2005-07-27 | 2007-08-01 | Yakult Honsha Kk | Aqueous solution preparation containing camptothecins |
TW200738680A (en) * | 2005-08-04 | 2007-10-16 | Hoffmann La Roche | Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents |
CA2616075A1 (en) * | 2005-08-08 | 2007-02-15 | Hans-Willi Krell | Pyrazole derivatives, their manufacture and their use as pharmaceutical agents |
US20090093491A1 (en) * | 2005-09-30 | 2009-04-09 | Wolfgang Jenni | Diazine Azole Derivatives, Their Manufacture and Use as Pharmaceutical |
WO2008034579A1 (en) * | 2006-09-20 | 2008-03-27 | F. Hoffmann-La Roche Ag | 2-heterocyclyl-5-phenoxymethylpyridine derivatives as anticancer agents |
EP2103620A1 (en) | 2006-12-12 | 2009-09-23 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
EP2140883B1 (en) | 2007-04-20 | 2012-10-31 | Daido Chemical Corporation | Novel base for dry solid dispersion, solid dispersion containing the base, and composition containing the dispersion |
US20090233937A1 (en) | 2008-03-12 | 2009-09-17 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
AR073680A1 (es) * | 2008-09-26 | 2010-11-24 | Takeda Pharmaceutical | Prevencion y tratamiento de cancer con la mutacion del gen ras. composicion farmaceutica. uso. |
WO2010036928A1 (en) * | 2008-09-26 | 2010-04-01 | Takeda Pharmaceutical Company Limited | Prevention and treatment of cancer with lkb1 non-expression (deletion or mutation) |
EP2484383B1 (en) | 2009-09-30 | 2021-04-28 | Kabushiki Kaisha Sangi | Method for improving the aqueous solubility of poorly-soluble substances |
JP5705206B2 (ja) | 2010-02-26 | 2015-04-22 | 日新化成株式会社 | 硬カプセルおよびその製造方法 |
WO2011153050A1 (en) | 2010-06-02 | 2011-12-08 | The Trustees Of The University Of Pennsylvania | Methods and use of compounds that bind to her2/neu receptor complex |
US8993634B2 (en) | 2010-06-02 | 2015-03-31 | The Trustees Of The University Of Pennsylvania | Methods and use of compounds that bind to Her2/neu receptor complex |
JP5909796B2 (ja) | 2012-03-02 | 2016-04-27 | 株式会社サンギ | 難溶性物質の水溶解性改善方法 |
EP2902014B1 (en) | 2012-09-26 | 2019-03-06 | Takeda Pharmaceutical Company Limited | Process for producing solid particles |
US9468681B2 (en) | 2013-03-01 | 2016-10-18 | California Institute Of Technology | Targeted nanoparticles |
EP3317323B1 (en) | 2015-07-01 | 2021-05-26 | California Institute of Technology | Cationic mucic acid polymer-based delivery systems |
EP3238711B1 (en) | 2016-04-26 | 2023-07-12 | Mitsubishi Chemical Corporation | Base for solid dispersion, production method for solid dispersion using same, and solid dispersion |
CA2995617A1 (en) * | 2017-11-03 | 2019-05-03 | Universite De Montreal | Heterocyclic mitochondrial activity inhibitors and uses thereof |
CA3099440A1 (en) | 2018-06-13 | 2019-12-19 | California Institute Of Technology | Nanoparticles for crossing the blood brain barrier and methods of treatment using the same |
WO2020130125A1 (ja) | 2018-12-21 | 2020-06-25 | 第一三共株式会社 | 抗体-薬物コンジュゲートとキナーゼ阻害剤の組み合わせ |
CN118767143A (zh) | 2019-12-12 | 2024-10-15 | 听治疗有限责任公司 | 用于预防和治疗听力损失的组合物和方法 |
CN114217025B (zh) * | 2021-12-17 | 2024-01-23 | 哈尔滨工业大学 | 评估空气质量浓度预测中气象数据对其影响的分析方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU658567B2 (en) | 1990-04-16 | 1995-04-27 | Rhone-Poulenc Rorer International (Holdings) Inc. | Styryl-substituted indole and pyridyl compounds |
EP0912562A1 (en) * | 1996-07-19 | 1999-05-06 | Takeda Chemical Industries, Ltd. | Heterocyclic compounds, their production and use |
-
2001
- 2001-04-03 PE PE2001000307A patent/PE20011178A1/es not_active Application Discontinuation
- 2001-04-05 EE EEP200200576A patent/EE200200576A/et unknown
- 2001-04-05 SK SK1413-2002A patent/SK14132002A3/sk unknown
- 2001-04-05 CN CN01807792A patent/CN1444582A/zh active Pending
- 2001-04-05 BR BR0109851-9A patent/BR0109851A/pt not_active Application Discontinuation
- 2001-04-05 CZ CZ20023264A patent/CZ20023264A3/cs unknown
- 2001-04-05 CA CA002404760A patent/CA2404760A1/en not_active Abandoned
- 2001-04-05 KR KR1020017011568A patent/KR20020028865A/ko not_active IP Right Cessation
- 2001-04-05 AU AU2001244726A patent/AU2001244726A1/en not_active Abandoned
- 2001-04-05 US US09/889,974 patent/US6716863B2/en not_active Expired - Fee Related
- 2001-04-05 HU HU0300434A patent/HUP0300434A3/hu unknown
- 2001-04-05 WO PCT/JP2001/002937 patent/WO2001077107A1/en not_active Application Discontinuation
- 2001-04-05 EP EP01917827A patent/EP1268473A1/en not_active Withdrawn
- 2001-04-05 OA OA1200200311A patent/OA12244A/en unknown
- 2001-04-05 MX MXPA02009621A patent/MXPA02009621A/es unknown
- 2001-04-05 IL IL15211501A patent/IL152115A0/xx unknown
- 2001-04-05 PL PL01365787A patent/PL365787A1/xx not_active Application Discontinuation
- 2001-04-06 CO CO01027571A patent/CO5261589A1/es not_active Application Discontinuation
-
2002
- 2002-10-02 NO NO20024742A patent/NO20024742L/no not_active Application Discontinuation
-
2003
- 2003-07-17 US US10/620,706 patent/US20040024035A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20024742D0 (no) | 2002-10-02 |
WO2001077107B1 (en) | 2001-12-20 |
CO5261589A1 (es) | 2003-03-31 |
CA2404760A1 (en) | 2001-10-18 |
MXPA02009621A (es) | 2003-05-14 |
OA12244A (en) | 2006-05-10 |
US6716863B2 (en) | 2004-04-06 |
PE20011178A1 (es) | 2001-11-19 |
PL365787A1 (en) | 2005-01-10 |
BR0109851A (pt) | 2003-06-03 |
EP1268473A1 (en) | 2003-01-02 |
CN1444582A (zh) | 2003-09-24 |
IL152115A0 (en) | 2003-05-29 |
US20040024035A1 (en) | 2004-02-05 |
SK14132002A3 (sk) | 2003-04-01 |
KR20020028865A (ko) | 2002-04-17 |
WO2001077107A8 (en) | 2003-02-13 |
CZ20023264A3 (cs) | 2003-02-12 |
HUP0300434A2 (hu) | 2003-06-28 |
AU2001244726A1 (en) | 2001-10-23 |
WO2001077107A1 (en) | 2001-10-18 |
NO20024742L (no) | 2002-11-25 |
HUP0300434A3 (en) | 2004-11-29 |
US20020173526A1 (en) | 2002-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200200576A (et) | Oksasooli derivaadid ja nende kasutamine türosiini kinaasi inhibiitoritena | |
EE200200715A (et) | Asendatud kinasoliini derivaadid ja nende kasutamine inhibiitoritena | |
EE200300085A (et) | Pürasooli derivaadid ja nende kasutamine proteiini kinaasi inhibiitoritena | |
DK1000039T3 (da) | Substituerede quinazolinderivater og anvendelse deraf som tyrosinkinaseinhibitorer | |
DK1650203T3 (da) | Quinolinonderivater som tyrosinkinaseinhibitorer | |
NO20021820D0 (no) | Tyrosinkinaseinhibitorer | |
NO20023713D0 (no) | 2-benzotiazolyl-urea-derivater samt anvendelse derav som proteinkinaseinhibitorer | |
EE200300459A (et) | Uued spirotritsüklilised derivaadid ja nende kasutamine fosfodiesteraas-7 inhibiitoritena | |
IS6968A (is) | Nýir týrósínkínasa tálmar | |
ATE253576T1 (de) | 8-chinolinxanthin and 8-isochinolinxanthin derivate als pde 5 inhibitoren | |
EE200300071A (et) | Kinasoliini derivaadid | |
NO20014970D0 (no) | Cyklisk protein-tyrosin-kinase-inhibitor | |
IS6524A (is) | 5-alkýlpyrídó(3-3-D)pyrimídín týrósín kínasa tálmar | |
EE200100659A (et) | Diaminotiasoolid ja nende kasutamine proteiinikinaaside pärssimiseks | |
ATE269701T1 (de) | Gyrase-inhibitoren und ihre verwendung | |
EE200300491A (et) | 6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena | |
EE200100371A (et) | Amidinobensüülamiini derivaadid ja nende kasutamine trombiini inhibiitoritena | |
AR028068A1 (es) | Nuevos derivados de 1,1-dioxotiocromano y su uso como inhibidores de trombina | |
NO20025884D0 (no) | 2-aminotiazolinderivater og deres anvendelse som NO- syntaseinhibitorer | |
IDP000027420A (id) | Inhibitor-inhibitor kinase pirolotriazin | |
AU2002358198A1 (en) | Benzimidazole derivatives and their use as kdr protein kinase inhibitors | |
AU2002317319A1 (en) | Quinoline derivatives and their use as tyrosine kinase inhibitors |